Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2020 Jan;30(1):290-295.
doi: 10.1007/s11695-019-04154-2.

Effects of Roux-en-Y Gastric Bypass on Osteoclast Activity and Bone Density in Morbidly Obese Patients with Type 2 Diabetes

Laurel L Tangalakis  1 , Lawrence Tabone  2 , Anna Spagnoli  3 , Mike Muehlbauer  4 , Philip Omotosho  3 , Alfonso Torquati  3
Affiliations
Controlled Clinical Trial

Effects of Roux-en-Y Gastric Bypass on Osteoclast Activity and Bone Density in Morbidly Obese Patients with Type 2 Diabetes

Laurel L Tangalakis et al. Obes Surg. 2020 Jan.

Abstract

Introduction: Roux-en-Y gastric bypass (RYGB) is a well-established treatment for morbid obesity and type 2 diabetes. The effects of RYGB on bone metabolism and bone health are largely unknown.

Objective: Determine the changes in osteoclast function and bone density 1 year after RYGB as compared with a control group undergoing a diabetes support and education program (DSE).

Design: A prospective cohort study with patients matched for weight and age assigned to RYGB or DSE.

Setting: Large academic institution.

Patients or other participants: Patients with type 2 diabetes mellitus and morbid obesity (body mass index greater than 35 kg/m2).

Intervention: Subjects either received laparoscopic RYBG or DSE, which consisted of nutritional, exercise, and dietary counseling performed by a certified diabetic educator and a nutritionist three times over a year.

Main outcome measure: Osteoclast activity, bone mineral density.

Results: One year after, intervention subjects undergoing RYGB have a 280% increase in osteoclast activity as compared with a 7.6% increase in the DSE control group (P < 0.001). Furthermore, there was a statistically significant increase in sclerostin levels in subjects undergoing RYGB compared with an increase in the control group. The total bone mineral density was statistically unchanged within 1 year of intervention in both groups. A statistically significant decrease in bone mineral density in the left ribs (decrease of 6.8%, P < 0.05) and lumbar spine (decrease of 4.0%, P < 0.05) was seen 1 year after RYGB.

Conclusions: There is a significant increase in osteoclast activity observed 1 year after RYGB; the long-term clinical implications of this increased bone metabolism are unknown.

Keywords: Bariatric surgery; Bone loss; Bone mineral density; Osteoclast; Roux-en-Y gastric bypass.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Osteoclastic activity 12 months after Roux-en-Y gastric bypass. Serum concentration (ng/mL) of C-terminal telopeptides of type I collagen (CTX) given as mean ± standard deviation. *Significant difference at 12 months in CTX concentration in subjects who underwent RYGB versus the control group (P < 0.05, 2-tailed t test)
Fig. 2
Fig. 2
Circulating sclerostin in the gastric bypass group. Serum concentration (pmol/L) of sclerostin given as mean ± standard deviation
Fig. 3
Fig. 3
Circulating sclerostin in the control group. Serum concentration (pmol/L) of sclerostin given as mean ± standard deviation
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8): 806–14. - PMC - PubMed
    1. Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes. 2013;37(6):889–91. - PMC - PubMed
    1. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg. 2009;19(12):1605–11. - PubMed
    1. Khoo CM, Chen J, Pamuklar Z, et al. Effects of Roux-en-Y gastric bypass or diabetes support and education on insulin sensitivity and insulin secretion in morbidy obese patients with type 2 diabetes. Ann Surg. 2014;259(3):494–501. - PMC - PubMed
    1. Pizzorno L Bariatric surgery: bad to the bone, part 1. Integr Med. 2016;15(1):48–54. - PMC - PubMed

Publication types

MeSH terms